Sandor Batkai
Co-founder, VP Head of Translational Science @Genkardia
Signup · Get unlimited contacts
WORK HISTORY
Co-founder, VP Head of Translational Science @Genkardia
EDUCATION
Semmelweis University
Doctor of Philosophy (Ph.D.)
Semmelweis University
Doctor of Medicine (MD)
Ruprecht-Karls-Universität Heidelberg / Heidelberg University
Doctor of Medicine - MD
ABOUT SANDOR BATKAI
Medical Director | Drug Development Expert | Life Science StrategistI am passionate about translating cutting-edge science into transformative therapies. With deep expertise in RNA-based drug development in the cardiovascular and metabolic field, I have spent my career guiding biotech innovations from early-stage discovery to clinical impact.I keep helping biotech companies navigate the complexities of drug development, scientific strategy, and portfolio growth—turning breakthrough science into real-world success.At Resalis Therapeutics, my clinical and scientific insights are critical in advancing the development of our lead candidate, RES-010. As Co-founder of Cardior Pharmaceuticals, I played pivotal role in the development of a miRNA inhibitor for heart failure, contributing to the company’s successful acquisition by Novo Nordisk in 2024. My Expertise: Leading scientific strategy in biotech and drug development Advising on R&D roadmaps, clinical translation, and competitive landscape Coaching teams on RNA/ASO therapeutics, biotechnology strategy, and innovationI believe that the most impactful biotech breakthroughs happen when science, strategy, and leadership align. If you’re looking for a trusted expert to help shape the future of your innovation, let’s connect.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.